Compare NTRB & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTRB | MCHX |
|---|---|---|
| Founded | 2016 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.7M | 71.6M |
| IPO Year | N/A | 2004 |
| Metric | NTRB | MCHX |
|---|---|---|
| Price | $4.80 | $1.67 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 20.6K | 17.9K |
| Earning Date | 12-11-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,278,321.00 | ★ $46,494,000.00 |
| Revenue This Year | $30.17 | N/A |
| Revenue Next Year | $3,394.36 | $6.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.69 | N/A |
| 52 Week Low | $3.72 | $1.26 |
| 52 Week High | $11.78 | $2.31 |
| Indicator | NTRB | MCHX |
|---|---|---|
| Relative Strength Index (RSI) | 45.40 | 49.67 |
| Support Level | $4.34 | $1.60 |
| Resistance Level | $4.77 | $1.73 |
| Average True Range (ATR) | 0.37 | 0.07 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 38.63 | 37.36 |
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Marchex Inc harnesses the power of AI and conversational intelligence to provide actionable insights aligned with prescriptive vertical market data analytics, driving operational excellence and revenue acceleration. Marchex enables executive, sales, and marketing teams to optimize customer journey experiences across communications channels, enabling enterprise strategies, empowering businesses to increase revenue through informed decision-making and strategic execution.